Use access key #2 to skip to page content.
$10.40 -0.50 (-4.59%)
1/9/2009 3:08 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar TrademDave (70.99) Submitted: 9/11/07 11:29 AM : Outperform Start Price: $16.56 ALKS Score: 1.73

ALKS has a good pipeline and good partnership with major drug companies. Current price is in the upper mid range of the 52wk hi-lo. Good buy in the 16.50 range.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links